China Medical GatewayLoading your healthcare gateway…

Cui Xin Gang

Cui Xin Gang — Chief Physician — Urology — Shanghai Xinhua Hospital

Specialties

1. Laparoscopic, robotic surgery, and comprehensive treatment for urinary system tumors. 2. Especially skilled in personalized nephron-sparing surgery for complex adult and pediatric kidney tumors, and removal of giant renal carcinoma with inferior vena cava tumor thrombus. 3. Robotic radical prostatectomy for various complex prostate cancers, etc.

Education

Postdoctoral

Professional Experience

Cui Xingang, male, postdoctoral researcher, chief physician, professor, doctoral supervisor, Director of the Department of Urology at Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Clinically, he focuses on minimally invasive techniques in urology, particularly excelling in robotic/laparoscopic surgery for urinary system tumors. He performs over 1,000 surgeries annually as the lead surgeon and conducts more than 500 external consultations. Each year, he leads approximately 600 robotic/laparoscopic kidney tumor surgeries, with a renal-sparing surgery rate exceeding 80% for kidney tumors. He has spoken at major international urology conferences including the SIU, the CUA National Annual Meeting, and the CUDA National Annual Meeting, and has performed live surgery demonstrations at domestic and international academic meetings such as the Asian Urology Conference, the Sino-European Urological Laparoscopy Conference, and the National Urology Annual Meeting multiple times. He is the associate editor for the revised edition of "Wu Jieping's Urology" (basic and surgical volumes) and contributed to the 2019 edition of the "Chinese Guidelines for Diagnosis and Treatment of Urological Diseases," specifically the "Guidelines for Diagnosis and Treatment of Renal Cell Carcinoma." He is a well-known domestic expert in laparoscopic urological surgery. Cui actively explores innovative techniques in urological laparoscopy and has made a series of innovations, with related research published in journals such as Urology, BJU, and the Chinese Journal of Urology. His research results were continuously included in the European Association of Urology (EAU) guidelines from 2017 to 2020: 1. He was the first in China to report the combination of 3D printing with intraoperative ultrasound technology, applying 3D printing to surgeries for complex kidney tumors, significantly increasing surgical precision and success rates. 2. He was the first in China to propose the "early renal artery open '2+1' suture technique" in laparoscopic renal unit-sparing surgery, significantly reducing renal warm ischemia time, improving surgical safety, and decreasing intraoperative bleeding. He has performed live surgery demonstrations at more than ten major domestic conferences and given multiple conference speeches. 3. He was among the earliest in China to propose the "early sequential blood flow opening method" for laparoscopic renal unit-sparing surgery. By sequentially blocking and releasing blood flow, transitioning renal artery control from full occlusion to super-selective occlusion to zero ischemia, this method significantly reduces renal ischemia time and effectively preserves kidney function. 4. He was the first in China to carry out zero-occlusion renal-sparing surgery using the pre-placed suture method. By pre-leaving sutures, rapid intraoperative suturing is enabled, allowing precise suturing of renal wounds in cases of intraoperative bleeding, accelerating suture speed and effectively repairing renal wound edges. 5. Domestically, the preoperative interventional embolization technique was first applied for 'zero ischemia' partial nephrectomy. By precisely embolizing the tumor-supplying vessels before surgery, intraoperative bleeding can be significantly reduced, suturing difficulty lowered, and the surgical field kept clear, allowing kidney-sparing surgery without blocking the renal artery. This technique is particularly suitable for cases with renal insufficiency, minimizing kidney damage and promoting rapid patient recovery. Actively promoting standardized laparoscopic kidney-sparing procedures, serving as a training mentor for 'Kidney Warriors', and the work 'Application of Laparoscopic Techniques in Urology' won the second prize of military medical achievements. Successfully organized the first Urological Endoscopy Annual Meeting of the Chinese Medical Association, the Second Military Medical University Surgery Week, and multiple national advanced laparoscopic training courses, with approximately 3,000 participants, contributing to the dissemination and application of laparoscopic techniques in domestic urology. Actively emphasizing the transformation of research achievements, obtaining approval for 23 laparoscopic-related patents. As the first author, awarded the Shanghai Medical New Technology. In teaching, supervised 25 doctoral students and 19 master’s students. Meticulously involved in undergraduate and graduate teaching, edited two books as the chief editor, co-edited eight books, and contributed to multiple teaching books and monographs. Received the second prize in the 5th Young Teachers Teaching Competition of the Chinese Medical Association. The project 'Clinical Surgery-Assisted PBL and CBL Teaching Innovation Exploration' received the second prize at the university-level teaching achievement awards. Received the school's 'A' grade teacher, 'Excellent Undergraduate Supervisor', 'Advanced Teaching Individual', and 'Outstanding Young Teacher in Shanghai Higher Education'. Led undergraduates to consecutively win over 10 awards including the first prize in the University Student Life Science Competition at the university, Shanghai city first prize, national first prize, and the Gold Award in the China International College Students’ Entrepreneurship Competition. Mentored over 20 outstanding young talents including 6 'Outstanding Graduates' of Shanghai, 1 'Morning Star Program Talent' of Shanghai, 3 'Yangfan Program Talents' of Shanghai, 2 'Excellent Young Physicians' of Shanghai Medical Star, 1 'Super Postdoctoral Fellow' of Shanghai, and 1 in the first 'Bole Program' of Shanghai Jiao Tong University. Principal investigator for 6 projects funded by the National Natural Science Foundation (including 2 key projects), National Key R&D Programs, major clinical research projects by the Shanghai Shenkang Center, Shanghai 'Science and Technology Innovation Action Plan' projects, key innovation projects of the Shanghai Municipal Education Commission, and 25 other projects, with a total funding of 54.007 million yuan. Selected for multiple talent programs including Shanghai "Leading Talent" (Oriental Talent - Leading Project), Shanghai "Medical Leading Talent", Shanghai "Outstanding Academic Leader", Shanghai Medical New Star "Outstanding Young Medical Talent", and the Mengchao Talent Training Program - Reserve Training Program for Leading Talents. Awarded multiple honors such as Shanghai Craftsman, Shanghai "Medical Craftsman", National Health System "Advanced Worker", Chinese Medical Association Urology Branch "Guo Yinglu Urology Young Physician Award", "Benevolent Doctor" Shanghai Outstanding Specialist Physician Nomination, Shanghai Medical Association Urology and Andrology 2017 "Figure of the Year" Award. Led teams to win scientific and technological awards including Shanghai Science and Technology Progress Award First Prize, Ministry of Education Science and Technology Progress Award First Prize, and Huaxia Medical Science and Technology Award Third Prize. Serves as executive editor for journals including the Chinese Journal of Urology and Chinese Journal of Endoscopic Urology (Electronic Edition). (1) 2025.12 Shanghai "Craftsman" (2) 2025.07 Shanghai "Medical Craftsman" (3) 2025.04 National Health System "Advanced Worker" (4) 2024.12 Shanghai "Leading Talent" (Oriental Talent Plan - Leading Project) (5) 2024.05 Shanghai Science and Technology Progress Award First Prize (6) 2024.02 Xinhua Hospital "Science and Education Innovation Award" (individual) (7) 2022.11 Huaxia Medical Science and Technology Third Prize (8) 2022.09 Shanghai Medical "Leading Talent" (9) 2019.03 Shanghai Outstanding Academic Leader (10) 2019.02 Shanghai Outstanding Young Medical Talent (11) 2018.11 Chinese Medical Association Urology Branch "Guo Yinglu Urology Young Physician Award" (12) 2018.06 Shanghai Medical Association Urology and Andrology 2017 "Figure of the Year" Award (13) 2017.12 Ministry of Education Science and Technology Progress Award First Prize 1. National Natural Science Foundation Regional Joint Key Project: Study on the mechanism by which the PACAP neuro-immune axis mediates immunotherapy resistance in renal cancer through regulation of the inhibitory immune microenvironment, 2026/01-2029/12, 2.57 million RMB 2. National Natural Science Foundation Key Project: Study on the mechanism and intervention strategies of tumor-associated macrophage LGALS9 TAM-mediated renal cancer TKI resistance and immunosuppression. 2024/01-2028/12, 2.2 million yuan 3. National Key R&D Program of China, Key Project on Disruptive Technology Innovation, IIT clinical trial study on deaggregation therapy for cavity tumors, 2024/10-2026/09, 2.4 million yuan 4. Shanghai Oriental Talent Project, Shanghai 'Leading Talent', 2025/01-2027/12, 1.2 million yuan 5. Shanghai Municipal Health Commission Leading Health Talent, Study on the role and regulatory mechanism of HECW1 in renal cancer progression through the interaction between renal cancer and tumor-associated macrophages, 2023/01-2025/12, 450,000 yuan 6. National Natural Science Foundation of China General Program, Study on the mechanism of EDD1 in regulating the interaction between renal cancer and macrophages via CCL8 in renal cancer progression, 2022/01-2025/12, 547,000 yuan 7. National Natural Science Foundation of China General Program, Study on the regulatory mechanism of Gankyrin in renal cancer progression through the interaction between renal cancer and macrophages, 2020/01-2023/12, 550,000 yuan 8. National Natural Science Foundation of China General Program, Study on the mechanism by which USP39 regulates AR-V7 variant splicing maturation and mediates castration resistance in prostate cancer, 2018/01-2021/12, 450,000 yuan 9. Shanghai Science and Technology Committee Excellent Academic Leader Program, Study on the role and mechanism of SOX17 in renal cancer progression and drug resistance by regulating the tumor microenvironment constructed by renal cancer and macrophages, 2019/05-2022/04, 400,000 yuan

Professional Roles

1. Standing Committee Member of the Urology Branch of the Chinese Medical Doctor Association 2. Deputy Director of the Youth Committee of the Urology Branch of the Chinese Medical Association 3. Deputy Director of the Perioperative Professional Committee of the Chinese Society of Integrative Medicine 4. Member of the Robotics Group of the Urology Branch of the Chinese Medical Association 5. Member of the Minimally Invasive Group of the Urology Branch of the Chinese Medical Association 6. Member of the Urological and Male Reproductive Tumor Professional Committee of the Chinese Anti-Cancer Association 7. Deputy Secretary-General of the Endoscopy Physicians Branch of the Chinese Medical Doctor Association 8. Deputy Secretary-General of the Urological Endoscopy Professional Committee of the Endoscopy Physicians Branch of the Chinese Medical Doctor Association 9. Member of the Urology Professional Committee of Standardized Resident Training of the Chinese Medical Doctor Association 10. Standing Committee Member of the Urology Professional Committee of the Integrative Medicine Branch of the Chinese Medical Doctor Association 11. Standing Committee Member of the Urology Branch of the Chinese Sexology Association 12. Member of the Medical Laser Equipment and Technology Professional Committee of the China Association for Medical Equipment 13. Standing Committee Member of the Robotics Professional Committee of the Chinese Society of Automation in Medicine 14. Vice President of the Medical Robotics Professional Committee of the Shanghai Medical Doctor Association 15. Director of the Perioperative Professional Committee of the Shanghai Society of Integrative Medicine 16. Member of the Urology Branch of the Shanghai Medical Association 17. Member of the Urology Branch of the Shanghai Medical Doctor Association 18. Deputy Director of the Youth Committee of the Andrology Branch of the Shanghai Medical Association 19. Member of the Urology Professional Committee of the Shanghai Association of Social Medical Institutions

Return to Home